This provider's $34.1M in total Medicare payments ranks in the 97th percentile of Clinical Laboratory providers nationally.
Medicare payments to this provider grew 48253% from 2014 to 2023.
AI-generated analysis based on Medicare payment data.
Notable: Payments increased 1013% in 2019
Year-over-year payment surges can indicate changes in practice volume, new services, or billing pattern shifts.
Average per-service amounts submitted by the provider compared to what Medicare actually paid — the gap represents the markup.
| Year | Avg Submitted | Avg Paid | Markup Ratio | Gap per Service | Total Payments | Services | Beneficiaries |
|---|---|---|---|---|---|---|---|
| 2014 | $62.35 | $44.14 | 1.41x | $18.21 | $28.1K | 637 | 2 |
| 2018 | $52.05 | $43.10 | 1.21x | $8.95 | $52.6K | 1.2K | 4 |
| 2019 | $50.33 | $39.04 | 1.29x | $11.29 | $585.4K | 15.0K | 5 |
| 2020 | $897.79 | $604.14 | 1.49x | $293.65 | $1.7M | 2.8K | 5 |
| 2021 | $1.1K | $806.42 | 1.40x | $322.19 | $8.1M | 10.1K | 19 |
| 2022 | $344.22 | $331.17 | 1.04x | $13.05 | $10.0M | 30.3K | 39 |
| 2023 | $334.29 | $327.41 | 1.02x | $6.88 | $13.6M | 41.5K | 26 |
| Code | Description | Services | Payments | Avg/Service | Markup |
|---|---|---|---|---|---|
| 81238 | Gene analysis (coagulation factor ix) full sequence analysis | 5.6K | $3.3M | $592.56 | 1.12x |
| 81411 | Test for detecting genes associated with heart disease, duplication/deletion analysis panel | 1.7K | $2.4M | $1.4K | 1.48x |
| 81442 | Gene analysis (noonan syndrome) genomic sequence analysis | 1.0K | $2.2M | $2.1K | 1.17x |
| 81226 | Gene analysis (cytochrome p450, family 2, subfamily d, polypeptide 6) common variants | 4.4K | $2.0M | $443.15 | 1.02x |
| 81321 | Gene analysis (phosphatase and tensin homolog), full sequence analysis | 3.2K | $1.9M | $588.83 | 1.02x |
| 81307 | Gene analysis (partner and localizer of brca2) full sequence analysis | 3.2K | $1.9M | $585.80 | 1.02x |
| 81162 | Gene analysis (breast cancer 1 and 2) of full sequence and analysis for duplication or deletion variants | 1.0K | $1.8M | $1.8K | 1.02x |
| 81201 | Gene analysis (adenomatous polyposis coli), full gene sequence | 2.7K | $1.8M | $656.11 | 1.03x |
| 81351 | Gene analysis (tumor protein 53) full sequence analysis | 2.6K | $1.6M | $630.09 | 1.02x |
| 81334 | Gene analysis (runt related transcription factor 1) targeted sequence analysis | 3.2K | $1.0M | $323.32 | 1.02x |
| 81439 | Test for detecting genes associated with inherited disease of heart muscle | 1.7K | $1000.0K | $572.39 | 1.34x |
| 81408 | Molecular pathology procedure level 9 | 482 | $963.7K | $2.0K | 1.25x |
| 81410 | Test for detecting genes associated with heart disease, genomic sequence analysis panel, at least 9 genes | 1.8K | $884.9K | $503.91 | 2.18x |
| 81314 | Gene analysis ((platelet-derived growth factor receptor, alpha polypeptide) targeted sequence | 2.6K | $829.3K | $323.42 | 1.02x |
| 81225 | Gene analysis (cytochrome p450, family 2, subfamily c, polypeptide 19) common variants | 2.6K | $750.3K | $286.27 | 1.02x |
| 81185 | Gene analysis (calcium voltage-gated channel subunit alpha1 a) of full sequence | 752 | $636.4K | $846.27 | 1.42x |
| 81272 | Gene analysis (v-kit hardy-zuckerman 4 feline sarcoma viral oncogene homolog), targeted sequence | 1.9K | $628.7K | $322.92 | 1.02x |
| 81218 | Gene analysis (ccaat/enhancer binding protein [c/ebp], alpha) full gene sequence | 2.6K | $608.8K | $237.43 | 1.02x |
| 81328 | Gene analysis (solute carrier organic anion transporter family, member 1b1) for common variant | 3.2K | $546.8K | $171.53 | 1.02x |
| 81227 | Gene analysis (cytochrome p450, family 2, subfamily c, polypeptide 9) common variants | 3.0K | $520.7K | $171.35 | 1.02x |
This provider submits charges 1.14 times higher than what Medicare actually pays.
A markup ratio of 1.14x means for every $100 Medicare pays, this provider initially charges $114. This is lower than the national average.
Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.
Other Clinical Laboratory providers in FL for peer comparison.
| Provider | Location | Total Payments | Status |
|---|---|---|---|
| Quest Diagnostics Clinical Laboratories Inc | Tampa, FL | $1.0B | ⚠️ Flagged |
| Laboratory Corporation Of America | Tampa, FL | $463.1M | ⚠️ Flagged |
| Quest Diagnostics Clinical Laboratories Inc | Miramar, FL | $417.1M | ⚠️ Flagged |
| American Health S, Llc | Davie, FL | $175.7M | ✓ Clear |
| Ameripath Florida Llc | Pompano Beach, FL | $80.1M | ✓ Clear |
Share this provider's Medicare payment information
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.
Believe this data is inaccurate? Dispute this data